-
Luis F.Z. Batista, Ph.D.
- Understanding the role of DNA damage and RNA degradation during tissue homeostasis, regeneration, aging, and cancer
-
Carmen Bergom, M.D., Ph.D.
- Identification of new targets to improve tumor radiation effectiveness and to protect normal tissues such as the heart from radiation injury
-
Kendall J. Blumer, Ph.D.
- Precision targeting of signal transduction for drug development in cancer
-
Kelly L. Bolton, M.D., Ph.D.
- The interplay between inherited genetic variation, environmental factors, and acquired mutations in shaping the earliest stages of carcinogenesis
-
Ron Bose, M.D., Ph.D.
- Genomics and Cell Signaling in Breast Cancer
-
Yin Cao, Sc.D., MPH
- Novel lifestyle, microbial, and genetic risk factors for lung and gastrointestinal cancers leveraging large-scale clinical and population-based cohorts with deep genetic and phenotypic data
-
Grant Challen, Ph.D.
- Understanding the genetic and epigenetic mechanisms that regulate normal and leukemic stem cells
-
Aadel A. Chaudhuri, M.D., Ph.D.
- Liquid biopsy cancer detection
-
David Y. Chen, M.D.,Ph.D.
- Defining the genetic and epigenetic drivers of premalignant states in skin cancer
-
Milan G. Chheda, M.D.
- Cancer stem cells, oncolytic viruses, and functional genomics of brain tumors
-
Jaebok Choi, Ph.D.
- Understanding T cells and immunoregulatory networks in GvHD and GvL for the treatment of hematopoietic malignancies.
-
Kyunghee Choi, Ph.D.
- Angioimmune interface in development, tissue regeneration, and cancer
-
Matt Christopher, M.D., Ph.D.
- Improve outcomes for patients with acute myeloid leukemia (AML) and other hematopoietic malignancies utilizing genomic and molecular biology techniques
-
Matthew A. Ciorba, M.D.
- Tryptophan metabolism and probiotic bacteria as modifiers of intestinal cancer and inflammation
-
Graham A. Colditz, M.D., Dr.P.H.
- Causes and prevention of chronic disease, particularly among women
-
David G. DeNardo, Ph.D.
- Molecular Mechanisms of Immune Regulation of Tumor Progression.
-
Carl DeSelm, M.D., Ph.D.
- Dr. DeSelm clinically focuses on treating lymphoma, and is actively developing novel CAR T cell approaches to treating solid tumors, including lymphoma, pancreatic cancer and glioblastoma.
-
Katherine C. Fuh, M.D., Ph.D.
- Identifying pathways involved in metastasis in the context of incorporating the tumor microenvironment of ovarian cancer
-
Matthew L. Goodwin, M.D., Ph.D.
- Metabolism of cancer, targeting tumor metabolism by blocking metabolic pathways
-
Abby M. Green, MD
- The etiology of mutagenesis and genome instability in pediatric cancers
-
Malachi Griffith, Ph.D.
- Improving our understanding of human disease biology and the development of personalized medicine strategies using genomics and informatics technologies
-
Obi L. Griffith, Ph.D.
- Development of personalized medicine strategies for cancer using genomic technologies
-
David H. Gutmann, M.D., Ph.D.
- Leveraging neurogenetic disorders to study normal brain development, cancer, and autism
-
Dennis E. Hallahan, M.D.
- The mechanisms of cell death in normal tissues during cancer therapy
-
Jason M. Held, Ph.D.
- Redox biochemistry in cell signaling and disease, Proteomics
-
Angela Hirbe, M.D., Ph.D.
- Utilization of genomic information from sarcomas to better understand the pathogenesis of these tumors and to identify biomarkers and therapeutic targets for these aggressive cancers.
-
Chyi-Song Hsieh, M.D., Ph.D.
- Understanding T cell tolerance to self and non-self
-
Joseph Ippolito, M.D., Ph.D.
- Sex differences in cancer metabolism and prostate cancer imaging
-
James W. Janetka, Ph.D.
- The rational structure-based drug design and synthesis for cancer and infectious disease
-
Charles Kaufman, MD, Ph.D.
- Understanding and modifying the mechanisms controlling the onset of melanoma cancer by integrating zebrafish models and human disease
-
Dineo Khabele, M.D.
- clinical and translational research in gynecologic oncology, with a focus on ovarian cancer
-
Albert H. Kim, M.D., Ph.D.
- Genetic and epigenetic changes that drive malignant behavior in brain tumors
-
Eynav Klechevsky, Ph.D.
- Human Dendritic Cell biology and Novel vaccines
-
Kian Lim, M.D., Ph.D.
- Understanding the role of inflammation in gastrointestinal cancers
-
Daniel C. Link, M.D.
- Regulation of normal and malignant hematopoiesis
-
Gregory D. Longmore, M.D.
- Cell Motility and Cancer Metastasis
-
Jeffrey Magee, M.D., Ph.D.
- Developmental context and genetic variation as underlying mechanisms of childhood cancer
-
Christopher Maher, Ph.D.
- Translational Cancer Genomics; Noncoding RNAs
-
Ben Major, Ph.D.
- Studying how perturbation of specific signal transduction pathways contributes to the initiation, progression and dissemination of cancer
-
Stephanie Markovina, M.D., Ph.D
- Studies novel metrics to serve dual purpose as biomarkers for prognosis and response to radiation therapy, as well as therapeutic targets for human solid tumors such as cervical and anal cancers.
-
Helen McNeill, Ph.D.
- Coordinating cell proliferation and cell organization in organ development
-
Shamim Mollah, Ph.D.
- Interpret and distill the complexity of cancer and other rare diseases through integration of large scale multi-omics data, special emphasis on phospho signaling pathways and post translational modification of histones
-
Nima Mosammaparast, M.D., Ph.D.
- Understanding the molecular mechanisms of the DNA damage response and DNA repair in human cells
-
Stephen Oh, M.D., Ph.D.
- Mechanisms of dysregulated signaling in blood cancers
-
Gary Patti, Ph.D.
- To understand the metabolic crosstalk between cells and tissues in disease models such as cancer by using isotopes and metabolomics
-
Jacqueline Elise Payton, M.D., Ph.D.
- Epigenomic aberrations in B cell lymphomas and their impact on gene regulation
-
Allegra A. Petti, Ph.D.
- We seek to understand tumor ecosystems at single-cell resolution during the development and evolution of human cancer
-
Sid Puram, M.D., Ph.D.
- Understanding the role of tumor heterogeneity in cancer biology, including its contributions to cancer development, growth, metastasis, and treatment resistance mechanisms, in order to translate these insights into new diagnostics and novel therapeutics
-
Lee Ratner, M.D., Ph.D.
- Molecular biology and pathogenesis of HIV and HTLV
-
Patricia Ribeiro Pereira, Ph.D.
- Molecular imaging tools to understand tumor biology and response to therapies
-
Joshua B. Rubin, M.D., Ph.D.
- Molecular mechanisms in pediatric brain tumorigenesis
-
Robert D. Schreiber, Ph.D.
- Cytokine receptor signaling and immunological protection against tumor development
-
Julie Schwarz, M.D., Ph.D.
- Studying cancer therapy resistance mechanisms in humans and preclinical models
-
Jieya Shao, Ph.D.
- Molecular mechanisms and therapeutic potential of novel cancer targets
-
Monica Shokeen, Ph.D.
- Development and evaluation of small- and macro-molecular agents for multi-modal molecular imaging of cancer and cardiovascular diseases
-
Nathan Singh, M.D., M.S.
- Understanding how synthetic antigen receptors direct T cell function and dysfunction in the treatment of blood cancers
-
George P. Souroullas, Ph.D.
- Understand how epigenetic mechanisms and chromatin dynamics contribute towards the development of cancer.
-
David H. Spencer, M.D., Ph.D.
- My research program studies epigenetic gene regulation in cancer, with a specific emphasis on understanding how mutations in acute myeloid leukemia (AML) perturb the epigenome to alter gene expression and cause leukemia.
-
Sheila A. Stewart, Ph.D.
- Examining the role the tumor microenvironment plays in immune modulation, tumor development, metastasis and dormancy
-
Stephen M. Sykes, Ph.D.
- Identify and define those molecular features that drive leukemogenesis and then use that information to develop rational therapeutic strategies for improving outcomes in acute leukemia
-
Adetunji T. Toriola, M.D., Ph.D.
- Associations of metabolic imbalance, inflamation with cancer etiology and survival
-
Brian Van Tine, M.D., Ph.D.
- Understanding the metabolism of sarcomas for therapeutic development
-
Priyanka Verma, Ph.D.
- Understanding DNA repair mechanisms that impact cancer etiology and responses to chemotherapies
-
Alessandro Vindigni, Ph.D.
- DNA replication and repair, and the roles of these pathways on cancer initiation, progression and response to chemotherapy and immunotherapy
-
Matthew J. Walter, M.D.
- Genetics and genomics of blood cancer: mutation discovery and mouse models
-
Jeffrey P. Ward, M.D., Ph.D.
- Identification of tumor specific mutant antigens recognized by the immune system as foreign that serve as the target of a T-cell response against tumors
-
Jason D. Weber, Ph.D.
- Tumor suppressor and oncogene networks in cancer biology
-
Katherine N. Weilbaecher, M.D.
- Molecular mechanisms through which tumor cells metastasize to bone
-
John Welch, M.D., Ph.D.
- Leukemic alternations of normal hematopoietic self-renewal and differentiation.
-
Mohamed A. Zayed, M.D.,Ph.D.
- The mechanisms that influence arterial collateral formation and peripheral arterial atheroprogression in the setting of diabetes
-
Jin Zhang, Ph.D.
- Developing cutting-edge and integrative data science approaches in translational cancer research
-
Chao Zhou, Ph.D.
- Developing novel optical imaging technologies for biomedical applications including cancer research and tissue engineering
|
|